According to a new report from Intel Market Research, the global epidural and spinal anesthesia drug market was valued at USD 1.25 billion in 2025 and is projected to grow from USD 1.31 billion in 2026 to USD 1.76 billion by 2034, exhibiting a steady CAGR of 5.1% during the forecast period (2026–2034). This growth is driven by increasing surgical volumes, rising preference for minimally...